title: Type II phospholipase A2 in human gestational tissues: extractable immuno- and enzymatic activity in fetal membranes.
abstract: In this study, we have established the presence of immunoreactive (ir) Type II PLA2 in human amnion and choriodecidua obtained from women at term prior to the onset of labour. The content of irType II PLA2 present in 1 M NaCl extracts of choriodecidua and amnion averaged 3.5 +/- 3.1 and 10.6 +/- 5.2 ng/mg tissue protein (n = 3), respectively. PLA2 enzymatic activity present in the same tissues averaged 1.3 +/- 0.2 and 1.9 +/- 0.7 nmol phosphatidylethanolamine (PE) hydrolysed/mg tissue protein per h (n = 3), respectively. To allow intra-patient comparison of the relative distribution in gestational tissues, irType II PLA2 and PLA2 enzymatic activity was also determined in placenta obtained from the same group of women, and averaged 26.0 +/- 7.0 ng/mg tissue protein and 3.5 +/- 1.0 nmol PE hydrolysed/mg protein per h (n = 3), respectively. As has been previously reported for human placenta, the recovery of Type II PLA2 and PLA2 enzymatic activity from amnion and choriodecidua was increased between 16- and 25-fold when tissues were homogenized in high-ionic strength media (i.e., 10% (w/v) ammonium sulphate or 1 M NaCl) compared with that recovered when tissues were homogenized in low-ionic strength media (i.e., 0.32 M sucrose-20 mM Hepes). The data obtained represent the first quantitative estimates of immunoreactive Type II PLA2 in human amnion and choriodecidua, and support the conclusion that previous analyses of the PLA2 enzymatic activity present in gestational tissues have essentially excluded the contribution made by this PLA2 isozyme to net enzymatic activity. We suggest that this isozyme represents a major component of the PLA2 enzymatic activity present in human gestational tissues at term and that it contributes significantly to the phospholipid metabolism and arachidonic acid release which occurs during late pregnancy and at the time of labour.
authors.affiliation: Department of Perinatal Medicine, Royal Women's Hospital, Carlton, Victoria, Australia.
authors.forename: M A
authors.initials: MA
authors.lastname: Aitken
authors.forename: W
authors.initials: W
authors.lastname: Farrugia
authors.forename: M H
authors.initials: MH
authors.lastname: Wong
authors.forename: K F
authors.initials: KF
authors.lastname: Scott
authors.forename: S P
authors.initials: SP
authors.lastname: Brennecke
authors.forename: G E
authors.initials: GE
authors.lastname: Rice
mesh_terms: D005321:Extraembryonic Membranes / Q000201:enzymology*; D005260:Female; D006801:Humans; D009994:Osmolar Concentration; D010741:Phospholipases A / Q000032:analysis / Q000302:isolation & purification* / Q000378:metabolism; D054467:Phospholipases A2; D010743:Phospholipids / Q000378:metabolism; D010920:Placenta / Q000201:enzymology*; D011247:Pregnancy
chemical_list: D010743:Phospholipids; D010741:Phospholipases A; D054467:Phospholipases A2